🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted steps to address household expense pressures" in next month's Budget.

Speaking to the BBC, she noted that lowering inflation is a joint task of both the administration and the central bank.

The United Kingdom's price growth is expected to be the highest among the G7 advanced economies this calendar year and the following year.

Possible Energy Bill Interventions

Reports indicate the administration could take action to lower energy bills, such as by reducing the current 5% level of value-added tax applied on energy supplies.

An additional possibility is to reduce some of the regulatory levies currently added to household expenses.

Budgetary Constraints and Expert Predictions

The government will obtain the latest draft from the official forecaster, the OBR, on Monday, which will reveal how much room there is for these actions.

The expectation from the majority of experts is that the Chancellor will have to declare higher taxes or spending cuts in order to adhere to her self-imposed borrowing rules.

Earlier on Thursday, estimates indicated there was a £22 billion gap for the Treasury chief to address, which is at the more modest range of forecasts.

"It is a joint task between the central bank and the government to continue tackling some of the causes of inflation," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and Global Issues

While much of the focus has been on expected tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing geopolitical and trade concerns for the fiscal tax moves, likely to be focused on those "most able to pay."

International Economic Disputes

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests always take priority."

Last week's announcement by Chinese authorities to tighten trade restrictions on rare earths and other resources that are essential for high-technology production led American leader Donald Trump to threaten an extra 100% import tax on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a international production control attempt."

Asked about accepting the American proposal to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's actions and urged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and generates additional challenges."

"It is my opinion there are sectors where we must confront Chinese policies, but there are also significant prospects to export to Chinese markets, including financial services and other sectors of the economy. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was collaborating with international partners "on our own essential resources plan, so that we are less reliant."

Health Service Medicine Costs and Funding

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could increase as a result of ongoing talks with the Trump administration and its drugs companies, in return for lower tariffs and capital.

A number of the biggest global drug companies have said lately that they are either delaying or abandoning investments in the United Kingdom, with several blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the price the health service pays for medicines would need to increase to prevent businesses and drug research funding departing from the United Kingdom.

Reeves told media: "We have seen due to the pricing regime, that drug testing, new drugs have not been available in the United Kingdom in the way that they are in other continental states."

"We want to guarantee that people getting care from the NHS are able to access the top life-saving drugs in the globe. And so we are looking at these issues, and... looking to attract additional funding into the UK."